With the ultimate goal of increasing pregnancy rates in infertile couples by up to 50%, Fertility Focus, the company behind OvuSense, has pioneered a new approach to infertility diagnosis and treatment for many years. After recently expanding the range of fertility monitoring products that work with the OvuSense app, the company has now announced a rebrand. To help distinguish between the fertility…
Earlier this week Jubel Health announced the launch of its app-based personal fertility guide. The platform was built together with leading reproductive doctors and other health experts as a one-stop-shop of resources to support women on their fertility journey. The newly launched Jubel app has been in public beta for a while, and features 24/7 chat for personalized information and insights, fireside…
TMRW Life Sciences, the creator of the world’s first and only automated technology platform for the management, identification, and storage of frozen eggs and embryos, announces today that Brian E. Miller, PhD, is joining TMRW’s senior leadership team as Senior Vice President of Sales. In his role, Brian will be responsible for bringing TMRW’s innovative technology to fertility clinics in the United States. Brian…
Clue, the company behind the popular period tracking app, has announced that it has received FDA clearance to launch a digital contraceptive. The new functionality allows users to prevent pregnancy based only on the start date of a user’s period. This algorithmic prediction is based on Bayesian modelling. The app will display a high risk window across a number of days of…
Dr. Raquel Hammonds is a Doctor of Medicine in Naturopathic Medicine. She comes from The Center for Reproductive Health & Gynecology in Beverly Hills, California, where she worked with patients to uncover the root cause of subfertility/infertility in men and women undergoing IVF and IUI. In January Dr. Hammonds has now joined Carrot Fertility as Director of Integrative and Preventative Medicine, a…
Women’s and Family Health Startup Maven has announced the expansion of its award-winning fertility program with the launch of MavenRx. Through partnerships with two specialty pharmacies, Maven members can now receive industry-leading price discounts on their medications, complimentary same-day or next-day shipping nationwide, and on-demand, pharmacist-led unboxing and injection support. MavenRx adds a critical layer of support for all U.S.-based employees covered…
ExEm Foam Inc announced today that ExEm Foam (air polymer-type A intrauterine foam), the only FDA-approved contrast agent for ultrasound tubal patency testing, is now available at select fertility clinics in the U.S.. The Foam procedure, a new ultrasound technique of hysterosalpingo foam sonography (HyFoSy), uses ExEm Foam to assess whether there may be a blockage in the fallopian tubes in women…
Ava, a digital healthcare company focused on women’s reproductive health, announced today it has received FDA clearance for its Ava Fertility Tracker, making it the first and only FDA-cleared fertility tracking wearable. A fertility tracking sensor bracelet and accompanying app, Ava Fertility Tracker is already the first and only wearable, machine learning device to aid women in ovulation prediction and facilitation of…
